Literature DB >> 11154018

The pathophysiology of agitation.

J P Lindenmayer1.   

Abstract

Agitation is a nonspecific constellation of relatively unrelated behaviors that can be seen in a number of different clinical conditions, usually presenting a fluctuating course. Multiple underlying pathophysiologic abnormalities are mediated by dysregulations of dopaminergic, serotonergic, noradrenergic, and GABAergic systems. Pathophysiologic mechanisms of agitation that operate in the different clinical disorders where agitation occurs are discussed. These pathophysiologic abnormalities are not associated with distinct clinical features. Although there may be a final common pathway, there is no unifying etiologic pathophysiology. The author suggests that the clinician address the underlying pathophysiology through a treatment intervention that addresses the overarching psychiatric disorder. Generally, agents that reduce dopaminergic or noradrenergic tone or increase serotonergic or GABAergic tone will attenuate agitation, often irrespective of etiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154018

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  28 in total

Review 1.  Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity.

Authors:  Cynthia L Bethea; Fernanda B Lima; Maria L Centeno; Karin V Weissheimer; Olga Senashova; Arubala P Reddy; Judy L Cameron
Journal:  J Chem Neuroanat       Date:  2011-06-06       Impact factor: 3.052

2.  A comparative study of emergence agitation between sevoflurane and propofol anesthesia in adults after closed reduction of nasal bone fracture.

Authors:  Young-Shin Kim; Young Keun Chae; Young Soon Choi; Jin-Hye Min; So Woon Ahn; Jong Won Yoon; Sang Eun Lee; Yong Kyung Lee
Journal:  Korean J Anesthesiol       Date:  2012-07-24

Review 3.  Alternative delivery systems for agents to treat acute agitation: progress to date.

Authors:  Kimberly Nordstrom; Michael H Allen
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 4.  Pharmacological management of agitation in emergency settings.

Authors:  A Yildiz; G S Sachs; A Turgay
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

5.  New treatments for agitation.

Authors:  Leslie Citrome
Journal:  Psychiatr Q       Date:  2004

6.  Function and innervation of the locus ceruleus in a macaque model of Functional Hypothalamic Amenorrhea.

Authors:  Cynthia L Bethea; Aaron Kim; Judy L Cameron
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

Review 7.  Pharmacological control of acute agitation: focus on intramuscular preparations.

Authors:  Dan L Zimbroff
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 8.  [Neurobiological principles of bipolar affective disorders].

Authors:  B Baumann; C Normann; H Bielau
Journal:  Nervenarzt       Date:  2003-07       Impact factor: 1.214

Review 9.  Intramuscular aripiprazole : a review of its use in the management of agitation in schizophrenia and bipolar I disorder.

Authors:  Mark Sanford; Lesley J Scott
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Anticonvulsants in the treatment of aggression in the demented elderly: an update.

Authors:  Benedikt Amann; Johannes Pantel; Heinz Grunze; Eduard Vieta; Francesc Colom; Ana Gonzalez-Pinto; Dieter Naber; Harald Hampel
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.